2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Oral Session

[O9] Oral Session 9 Genitourinary Cancer
【E】

Fri. Feb 18, 2022 8:20 AM - 9:50 AM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair:Keita Uchino(Department of Medical Oncology, NTT Medical Center Tokyo),Nobuaki Matsubara(Department of Medical Oncology, National Cancer Center Hospital East)
Discussant:Ken-ichi Tabata(Department of Urology, Kitasato University School of Medicine)

[O9-3] SNHG16 mediate cisplatin and gemcitabine resistance in upper tract urothelial carcinoma cells by sponging of miR-31-5p

Wei-Chi Hsu1,2,3, Wei-Ming Li1,3,4, A-Mei Huang2,5,6,7, Lin-Li Chang2,8, Hui-Hui Lin1,3, Wen-Jeng Wu1,2,3, Ching-Chia Li1,3, Hung-Lung Ke1,2,3,9 (1.Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, 2.Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, 3.Department of Urology, Kaohsiung Medical University Hospital, 4.Department of Urology, Ministry of Health and Welfare Pingtung Hospital, 5.Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, 6.Department of Biochemistry, School of Medicine, College of Medicine, Kaohsiung Medical University, 7.Department of Medical Research, Kaohsiung Medical University Hospital, 8.Department of Microbiology, School of Medicine, College of Medicine, Kaohsiung Medical University, 9.Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password